[ET Net News Agency, 26 July 2021] SSY GROUP (02005) fell 9.76% to HK$4.99, dipping
below the 100-D SMA of HK$5.183.
It hits an intra-day low of HK$4.97, and an intra-day high of HK$5.53. The total shares
traded was 13.22 million, with a value of HK$68.96m. The active buy/sell ratio is 28:72,
with net selling turnover of HK$28.04m. J.P. MORGAN BRO (HK) accounts for greatest net
responsive buying turnover of HK$4.04m, with volume weighted average price of HK$5.211.
INSTINET PACIFIC accounts for greatest net responsive selling turnover of HK$2.2m, with
volume weighted average price of HK$5.232. The stock has fallen a combined 23.93% over the
past 5 consecutive trading days.
The Hang Seng Index now fell 900 points, or 3.29% to 26,421; the Hang Seng China
Enterprises Index now fell 417 points, or 4.24% to 9,421; the Hang Seng TECH Index now
fell 487 points, or 6.71% to 6,780; with an overall turnover of HK$151.5b.
The SSE Composite Index now fell 112 points, or 3.17% to 3,437, with an overall turnover
of RMB442.6b.
The SZSE Component Index now fell 591 points, or 3.93% to 14,437, with an overall
turnover of RMB297.53b.

Basic Information
-------------------------------------------
Nominal 4.990 % Chg -9.76%
High 5.530 Low 4.970
Shares Tr 13.22m Turnover 68.96m
10-D SMA 6.338 %H.V 111.120
20-D SMA 6.793 VWAP 5.218
50-D SMA 5.783 RSI14 33.324
-------------------------------------------
Status: Dipping below the 100-D SMA, active buy/sell ratio is 28:72, with net selling
turnover of HK$28.04m, falling a combined 23.93% over the past 5 consecutive
trading days

Table: Performance of stocks in the same sector or of relevance

Stock (Code) Price(HK$) Change(%)
-------------------------------------------------
SSY GROUP (02005) 4.99 -9.76
SIHUAN PHARM (00460) 2.40 -14.89
CHINAGRANDPHARM (00512) 6.08 -6.03
CSPC PHARMA (01093) 10.30 -4.45
SINO BIOPHARM (01177) 6.61 -5.44
3SBIO (01530) 7.13 -9.06
LUYE PHARMA (02186) 4.00 -8.26
FOSUN PHARMA (02196) 61.90 -8.97
WUXI APPTEC (02359) 161.10 -8.67
PHARMARON (03759) 157.90 -5.51
-------------------------------------------------
(ed)